Zarontin (ethosuximide)
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
May 2016
WARNINGS
Serious Dermatologic Reactions
Serious dermatologic reactions, including Stevens-Johnson syndrome (SJS), have...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts